Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease

The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2022-10, Vol.74, p.128942-128942, Article 128942
Hauptverfasser: Foot, Jonathan S., Buson, Alberto, Deodhar, Mandar, Findlay, Alison D., Robertson, Alan D., Turner, Craig I., Yow, Tin, Zhou, Wenbin, Jarolimek, Wolfgang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 128942
container_issue
container_start_page 128942
container_title Bioorganic & medicinal chemistry letters
container_volume 74
creator Foot, Jonathan S.
Buson, Alberto
Deodhar, Mandar
Findlay, Alison D.
Robertson, Alan D.
Turner, Craig I.
Yow, Tin
Zhou, Wenbin
Jarolimek, Wolfgang
description The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation. [Display omitted] The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.
doi_str_mv 10.1016/j.bmcl.2022.128942
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2703417705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X22004188</els_id><sourcerecordid>2703417705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</originalsourceid><addsrcrecordid>eNp9kLFOHDEQhi2USFxIXiCVS5q9jL2-tU9KAycgSEg0REpnee1ZMqe1DfaCOJ6ePR0NDdVI__zfSPMx9lPAUoDofm2XffTjUoKUSyHNWskjthCqU02rYPWFLWDdQTPn_47Zt1q3AEKBUgu22-TYU6J0z2NO2UVKyPMLBVeRn3OXAq8YybvSu1cK2FRMlSZ6Rv6xi-l1F5FT-k_9vM-JT5m7EArWOqfD6GJ0Uy47HqjiTHxnXwc3VvzxPk_Y38uLu82f5ub26npzdtN42bVT4zUoo31Ye40BQeo1gJHzj6YzCiSutBt6Y5wGaVoptetgAINolFh1Hnx7wk4Pdx9KfnzCOtlI1eM4uoT5qVqpoVVCa1jNVXmo-pJrLTjYh0LRlZ0VYPee7dbuPdu9Z3vwPEO_DxDOTzwTFls9YfIYqKCfbMj0Gf4G3XmILQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703417705</pqid></control><display><type>article</type><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><source>Elsevier ScienceDirect Journals</source><creator>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</creator><creatorcontrib>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</creatorcontrib><description>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation. [Display omitted] The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2022.128942</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Amine oxidase ; MAO-A ; MAO-B ; SSAO ; VAP-1 ; Vinyl fluoride</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2022-10, Vol.74, p.128942-128942, Article 128942</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</citedby><cites>FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X22004188$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Foot, Jonathan S.</creatorcontrib><creatorcontrib>Buson, Alberto</creatorcontrib><creatorcontrib>Deodhar, Mandar</creatorcontrib><creatorcontrib>Findlay, Alison D.</creatorcontrib><creatorcontrib>Robertson, Alan D.</creatorcontrib><creatorcontrib>Turner, Craig I.</creatorcontrib><creatorcontrib>Yow, Tin</creatorcontrib><creatorcontrib>Zhou, Wenbin</creatorcontrib><creatorcontrib>Jarolimek, Wolfgang</creatorcontrib><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><title>Bioorganic &amp; medicinal chemistry letters</title><description>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation. [Display omitted] The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</description><subject>Amine oxidase</subject><subject>MAO-A</subject><subject>MAO-B</subject><subject>SSAO</subject><subject>VAP-1</subject><subject>Vinyl fluoride</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kLFOHDEQhi2USFxIXiCVS5q9jL2-tU9KAycgSEg0REpnee1ZMqe1DfaCOJ6ePR0NDdVI__zfSPMx9lPAUoDofm2XffTjUoKUSyHNWskjthCqU02rYPWFLWDdQTPn_47Zt1q3AEKBUgu22-TYU6J0z2NO2UVKyPMLBVeRn3OXAq8YybvSu1cK2FRMlSZ6Rv6xi-l1F5FT-k_9vM-JT5m7EArWOqfD6GJ0Uy47HqjiTHxnXwc3VvzxPk_Y38uLu82f5ub26npzdtN42bVT4zUoo31Ye40BQeo1gJHzj6YzCiSutBt6Y5wGaVoptetgAINolFh1Hnx7wk4Pdx9KfnzCOtlI1eM4uoT5qVqpoVVCa1jNVXmo-pJrLTjYh0LRlZ0VYPee7dbuPdu9Z3vwPEO_DxDOTzwTFls9YfIYqKCfbMj0Gf4G3XmILQ</recordid><startdate>20221015</startdate><enddate>20221015</enddate><creator>Foot, Jonathan S.</creator><creator>Buson, Alberto</creator><creator>Deodhar, Mandar</creator><creator>Findlay, Alison D.</creator><creator>Robertson, Alan D.</creator><creator>Turner, Craig I.</creator><creator>Yow, Tin</creator><creator>Zhou, Wenbin</creator><creator>Jarolimek, Wolfgang</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221015</creationdate><title>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</title><author>Foot, Jonathan S. ; Buson, Alberto ; Deodhar, Mandar ; Findlay, Alison D. ; Robertson, Alan D. ; Turner, Craig I. ; Yow, Tin ; Zhou, Wenbin ; Jarolimek, Wolfgang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c263t-c70487cd9c7ede02790082128868402e57afb88a70283227a60f08ee84156c0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amine oxidase</topic><topic>MAO-A</topic><topic>MAO-B</topic><topic>SSAO</topic><topic>VAP-1</topic><topic>Vinyl fluoride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foot, Jonathan S.</creatorcontrib><creatorcontrib>Buson, Alberto</creatorcontrib><creatorcontrib>Deodhar, Mandar</creatorcontrib><creatorcontrib>Findlay, Alison D.</creatorcontrib><creatorcontrib>Robertson, Alan D.</creatorcontrib><creatorcontrib>Turner, Craig I.</creatorcontrib><creatorcontrib>Yow, Tin</creatorcontrib><creatorcontrib>Zhou, Wenbin</creatorcontrib><creatorcontrib>Jarolimek, Wolfgang</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Foot, Jonathan S.</au><au>Buson, Alberto</au><au>Deodhar, Mandar</au><au>Findlay, Alison D.</au><au>Robertson, Alan D.</au><au>Turner, Craig I.</au><au>Yow, Tin</au><au>Zhou, Wenbin</au><au>Jarolimek, Wolfgang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><date>2022-10-15</date><risdate>2022</risdate><volume>74</volume><spage>128942</spage><epage>128942</epage><pages>128942-128942</pages><artnum>128942</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation. [Display omitted] The discovery of a dual MAO-B/SSAO inhibitor PXS-5131 is reported. The compound offers a compact and rigid three-dimensional structure with superior selectivity over MAO-A. Potency and selectivity are linked to both the double bond geometry and stereochemistry of the allylamine moiety, highlighting the importance of optimal set up of these features in the class of amine oxidase inhibitors. PXS-5131 possesses an attractive preclinical pharmacokinetic profile and has anti-inflammatory properties in models of acute inflammation and neuroinflammation.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.bmcl.2022.128942</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2022-10, Vol.74, p.128942-128942, Article 128942
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_2703417705
source Elsevier ScienceDirect Journals
subjects Amine oxidase
MAO-A
MAO-B
SSAO
VAP-1
Vinyl fluoride
title Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T04%3A54%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combining%20monoamine%20oxidase%20B%20and%20semicarbazide-sensitive%20amine%20oxidase%20enzyme%20inhibition%20to%20address%20inflammatory%20disease&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Foot,%20Jonathan%20S.&rft.date=2022-10-15&rft.volume=74&rft.spage=128942&rft.epage=128942&rft.pages=128942-128942&rft.artnum=128942&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2022.128942&rft_dat=%3Cproquest_cross%3E2703417705%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2703417705&rft_id=info:pmid/&rft_els_id=S0960894X22004188&rfr_iscdi=true